metylperon has been researched along with raclopride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farde, L; Halldin, C; Wiesel, FA | 1 |
| Evans, DL; Figur, LM; Lahti, RA; Stratman, NC | 1 |
2 other study(ies) available for metylperon and raclopride
| Article | Year |
|---|---|
Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET.
Topics: Adult; Antipsychotic Agents; Butyrophenones; Female; Humans; Male; Prolactin; Psychotic Disorders; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Tomography, Emission-Computed | 1989 |
Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications.
Topics: Animals; Apomorphine; Butyrophenones; Cell Line; Chlorpromazine; Clozapine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Raclopride; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Salicylamides; Trifluoperazine | 1993 |